Fabupharm fought back against social media attacks claiming their children's fever medicine contains dangerous problems. Job Amupanda leads Affirmative Repositioning and serves as a parliament member who accused the company of making defective syrup. The drug maker operates as Namibia's only complete pharmaceutical manufacturer under local ownership. Managing director Francois Slabbert said their paracetamol syrup meets all safety rules and remains safe for families. The company stressed they never received official warnings from the Namibia Medicines Regulatory Council about product defects.
Slabbert explained his factory follows strict international manufacturing standards set by the World Health Organisation. Government Quality Surveillance Laboratory tests all Fabupharm products independently to ensure safety and effectiveness. The facility welcomes visitors and former finance minister Iipumbu Shiimi toured their Otjiwarongo plant. Company officials said no recalls or regulatory warnings have ever targeted their paracetamol syrup products. Slabbert asked people to stop sharing false information that scares families who depend on the medicine.
Amupanda claims medicine council inspectors found critical defects during facility visits and classified the syrup as substandard. The politician described the children's medicine as life-threatening and said authorities allowed dangerous distribution for two years. He suggested poor families using public hospitals face the greatest risk because they cannot afford private medical care. Amupanda questioned why regulatory officials kept inspection information secret for such a long period. The medicines council could not be reached for comment about the dispute.
Slabbert explained his factory follows strict international manufacturing standards set by the World Health Organisation. Government Quality Surveillance Laboratory tests all Fabupharm products independently to ensure safety and effectiveness. The facility welcomes visitors and former finance minister Iipumbu Shiimi toured their Otjiwarongo plant. Company officials said no recalls or regulatory warnings have ever targeted their paracetamol syrup products. Slabbert asked people to stop sharing false information that scares families who depend on the medicine.
Amupanda claims medicine council inspectors found critical defects during facility visits and classified the syrup as substandard. The politician described the children's medicine as life-threatening and said authorities allowed dangerous distribution for two years. He suggested poor families using public hospitals face the greatest risk because they cannot afford private medical care. Amupanda questioned why regulatory officials kept inspection information secret for such a long period. The medicines council could not be reached for comment about the dispute.
